Wacker Biotech is a global CDMO with production sites in Germany, the Netherlands and USA. The company is a pioneer in the manufacture of mRNA advanced therapies and vaccines, with diverse capabilities and backed by a strong R&D team in Munich, Germany:

• Manufacturing across the full value chain from pDNA to mRNA to LNPs at our pDNA competence center in San Diego, California and mRNA competence center in Halle, Germany.
• Supply of early R&D to GMP material with full QC release according to US Pharmacopeia and EU draft guidelines for RNA-based therapeutics.
• Dedicated team of scientists at our R&D hub that innovates new technologies through both internal development efforts and external collaborations.
• Development support for template DNA and RNA manufacturing processes from early R&D to GMP, with emphasis on manufacturability, including different strategies for RNA capping, co-transcriptionally and post-transcriptionally.
• Proprietary lipids and lipid libraries for LNP development at R&D and preclinical stage. 
• Client projects over the past five years that include an mRNA therapeutic for acute respiratory distress syndrome, the pDNA supply for an mRNA-based ophthalmology product, and work on an early COVID vaccine candidate.